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Leukocyte cell-derived chemotaxin 2 (LECT2) is a secreted hepatic protein that has been associated
with several physiological activities. LECT2 belongs to the peptidase M23 family, suggesting that it is
a zinc-binding protein. To test this possibility, electrospray ionization mass spectrometry and X-ray
absorption ﬁne-structure analysis were performed. Results of these experiments indicated that
recombinant mouse LECT2 produced by an animal cell line contains a zinc atom. Furthermore,
the recombinant LECT2 was found to be self-oligomerized by disulﬁde bonds in vitro, but this
was suppressed by addition of zinc. These results indicated that zinc stabilizes the LECT2 structure.
Structured summary of protein interactions:
LECT2 and LECT2 bind by cross-linking study (View interaction)
LECT2 and LECT2 bind by comigration in gel electrophoresis (View interaction)
LECT2 and LECT2 bind by comigration in gel electrophoresis (View interaction: 1, 2, 3)
LECT2 and LECT2 bind by cross-linking study (View interaction: 1, 2, 3)
LECT2 and LECT2 bind by comigration in gel electrophoresis (View interaction: 1, 2, 3)
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction In this report, the results of electrospray ionization mass spec-Leukocyte cell-derived chemotaxin 2 (LECT2) has been identiﬁed as
a human neutrophil chemotactic protein [1]. LECT2 is a secreted hepa-
tic proteinwith amolecularmass of approximately 16 kDa [2], and the
mammalian form has three disulﬁde bonds [3]. The protein-sequence
has been well conserved throughout evolution. Although accumulat-
ingevidence indicates thatLECT2 isassociatedwithseveralphysiologic
functions, their mechanisms are not yet clear [4–9].
LECT2 belongs to the peptidaseM23 structural family (PF01551),
as described in the pfamdata base (http://pfam.sanger.ac.uk),which
indicates it is a metalloprotease having a zinc ion as a cofactor.
Actually, many proteins of the M23 family have a zinc ion in their
catalytic domain that contributes to their protease activity. This
protein family iswidespread in bacteria, but LECT2 is the only verte-
brate protein in the M23 family. It is unclear whether LECT2 has a
protease activity.trometry (ESI-MS) and X-ray absorption ﬁne-structure (XAFS)
analysis indicate that recombinant mouse LECT2 produced by a
mammalian cell line contains a zinc atom. Furthermore, human
andmouse recombinant LECT2 proteins produced by an animal cell
line were found to be oligomerized by disulﬁde linkages in vitro.
This oligomerization was accelerated by the presence of EDTA or
EGTA and was inhibited by the presence of zinc ions. These results
indicate that LECT2 is a zinc-binding protein and that zinc contrib-
utes to the stability of the protein structure. They also suggest that
zinc plays a crucial role in the biological function of LECT2. More-
over, LECT2 has recently been reported as an amyloid protein
[10,11], suggesting that the oligomerization of LECT2 observed in
this study might be related to amyloid ﬁbril formation.
2. Materials and methods
2.1. The puriﬁcation of recombinant mouse LECT2 protein
Recombinant mouse LECT2 (GenBank accession number:
BAA33383) was puriﬁed using a procedure slightly modiﬁed from
the original [3]. A stable clone (clone No. 10G) of Chinese hamster
A. Okumura et al. / FEBS Letters 587 (2013) 404–409 405ovary (CHO) cells transfected with an expression vector having
mouse LECT2 cDNA was grown in Dulbecco’s modiﬁed Eagle’s
medium with 5% fetal bovine serum. Five liters of culture medium
were harvested and diluted with an equal volume of Milli-Q water.
CM-Sepharose fast ﬂow resin (GE Healthcare, Little Chalfont, UK),
pre-equilibrated with 50 mM Tris–HCl pH 7.5 (buffer A), was
added to the culture ﬂuid (30 ml resin) and stirred for 16 h at
4 C. The resin was collected by ﬁltration with aspiration over a
Kiriyama-rohto (95 mm in diameter, ﬁlter paper No. 5B; Kiriyama,
Tokyo, Japan), washed exhaustively with buffer A, and eluted with
buffer A supplemented with 0.5 M NaCl. The eluent was dialyzed
against buffer A overnight, and then loaded onto a Toyopearl
DEAE-650 M column (Tosoh, Tokyo, Japan) equilibrated with buffer
A. The pass-through fraction was recovered and applied again to
the Toyopearl CM-650 M column (Tosoh, Tokyo, Japan) equili-
brated with buffer A. After the CM column was washed with buffer
A, the proteins were eluted with a 0–0.7 M NaCl linear gradient in
buffer A. LECT2-containing fractions were identiﬁed using an ELISA
[5]. The fractions containing an appreciable amount of mouse
LECT2 were pooled and dialyzed against 50 mM Tris–HCl pH 7.5
containing 10% glycerol (buffer B). The dialysate was loaded onto
a Mono-S HR 5/5 column (GE Healthcare, Little Chalfont, UK) equil-
ibrated with buffer B and washed with buffer B containing 0.1 M
NaCl. Elution was then carried out with a linear gradient of 0.1–
0.5 M NaCl in buffer B. The fractions showing a single band on
SDS–PAGE by silver staining were pooled and dialyzed against
40 mM HEPES-NaOH pH 7.4, 10% glycerol, 100 mM NaCl. Recombi-
nant human LECT2 was also puriﬁed from the culture ﬂuid of an
established CHO cell line (clone name C1D8) as described previ-
ously [3,12].
2.2. Electrospray ionization mass spectrometry (ESI-MS)
ESI-MS experiments were performed on a Thermo Finnigan LCQ
Deca XP plus ion trap mass spectrometer (Thermo Scientiﬁc, Wal-
tham, MA, USA) equipped with a handmade nanospray tip
(0.1  50 mm). For the measurements under acidic and neutral
conditions, the ESI-MS spectra were acquired in positive ion mode
at a ﬂow rate of 1 ll/min with running solution consisting of
0.075% formic acid (pH 2.6) and 10 mM ammonium formate (pH
6.4), respectively. Recombinant mouse LECT2 was exchanged into
the same solution. Electrospray mass spectra were processed using
the Biomass convolution and deconvolution algorithms in the Bio-
works 3.1 software package (Thermo Scientiﬁc).
2.3. X-ray absorption ﬁne structure (XAFS)
Recombinant mouse LECT2 and a recombinant lysostaphin of
Staphylococcus simulans (Wako, Osaka, Japan) were dialyzed
against water prior to analysis. Each protein solution (100 lM)
was picked up with Litholoop (/ = 0.3 mm) and then was ﬂash-fro-
zen under a cryo-nitrogen stream at 100 K. The frozen samples
were shipped to SPring-8 BL26B2 for mail-in data collection [13].
The ﬂuorescence XAFS spectra of these proteins were measured
automatically by the SPring-8 Precise Automatic Cryo-sample Ex-
changer (SPACE) [14,15] in the energy range from 1.290000 to
1.276000 Å with an interval of 0.0001 Å for an exposure time of
3 s with a Si-PIN photodiode detector [16]. The XAFS spectra were
analyzed using the software D-Cha (database for crystallography
with home-lab arrangement) [13] to assign the wavelengths corre-
sponding to the peak and edge.
2.4. Analysis of LECT2 oligomerization in vitro
Twenty microliters of reaction buffer C (100 mM Tris–HCl pH
7.5, 150 mM NaCl) containing recombinant mouse LECT2 (1 lg)were incubated at 37 C. To assess the role of divalent ions, we
included 5 mM of each reagent (EDTA, EGTA, ZnCl2, MgCl2, CaCl2)
in the reaction solution. The reaction was stopped by adding an
equal volume of SDS–PAGE sample buffer (250 mM Tris–HCl pH
6.8, 10% lithium dodecyl sulfate, 20% glycerol, 0.04% bromophenol
blue) and incubating for 1 h at room temperature. The protein sam-
ples (2–8 ll) were subjected to SDS–PAGE on a 5–20% gradient
polyacrylamide gel and Western blotting using an anti-mouse
LECT2 polyclonal antibody [12]. To examine the reversibility of
the zinc ion binding to LECT2, we prepared an EDTA-free solution
and two EDTA-containing solutions. Forty microliters of buffer C
containing 2 lg of recombinant mouse LECT2 were incubated in
the presence or absence of 5 mM EDTA for 6 h at 4 C. Subse-
quently, the ETDA-free solution was dialyzed using an Xpress mi-
cro Dialyze Cartridge 3.5 kDa (Scienova GmbH, Jena, Germany)
against 2 ml of buffer C for 12 h as a control. Each of the EDTA-con-
taining solutions was dialyzed using the same cartridge against
buffer C (2 ml) with or without 5 mM ZnCl2 for 12 h at 4 C. The
three dialyzed solutions were then separately re-dialyzed three
times against 2 ml of buffer C for 12 h at 4 C. Finally, these solu-
tions were incubated for 24 h at 37 C and were subjected to
SDS–PAGE and Western blot analysis. All SDS–PAGE were carried
out under non-reducing conditions (without DTT treatment and
boiling) except when indicated speciﬁcally.
3. Results
3.1. Recombinant mammalian LECT2 contains a zinc atom
LECT2 is a member of the peptidase M23 structural family
(PF01551 in the pfam data base), indicating it is a metalloprotease
containing a zinc ion as a cofactor. Therefore, we ﬁrst attempted to
determinewhether LECT2 contains a zinc atom. EMI-MS is an appro-
priate technique with which to analyze peptide–metal interactions
[17]. We used the same preparation of the recombinant mouse
LECT2 that was analyzed previously using matrix-assisted laser
desorption/ionization time-of-ﬂight mass spectrometry [3], which
had indicated the only covalent modiﬁcation was the presence of
three disulﬁde bonds. Fig. 1 shows typical ESI-MS spectra of the re-
combinant mouse LECT2 under acidic and neutral conditions. The
deconvoluted results from analyzing the raw data (Fig. 1A and B)
are shown in Fig. 1C andD, respectively. Amass spectrumof the pro-
tein under denaturing acidic conditions showed only one predomi-
nant peak having a molecular mass of 14633 Da, which was almost
identical to the theoretical molecular mass of mature LECT2 [2]. On
theother hand, the spectrumof the proteinunder neutral conditions
showed a signiﬁcant signal of 14698 Da in addition to amajor signal
of 14633 Da that corresponded to the molecular weight revealed
under acidic conditions. The mass difference of these two signals is
65 Da, which is almost identical to the atomic weight of zinc.
To conﬁrm that the zinc atom is bound to LECT2, XAFS measure-
ments were performed. Typical proﬁles of XAFS experiments are
shown in Fig. 2. The XAFS proﬁle of recombinant mouse LECT2 in
Fig. 2A showed a K absorption edge of 1.2828 Å, indicating the pro-
tein contained a zinc atom [18]. A positive control experiment
using the zinc-binding protein lysostaphin [19,20] is shown in
Fig. 2B. The K absorption edge (1.2828 Å) wavelength indicating
zinc absorption in lysostaphin was identical to that seen in the
LECT2 XAFS data. These data indicate that recombinant mouse
LECT2 contains a non-covalently bound zinc atom and strongly
suggest that there is one zinc atom per molecule.
3.2. Oligomerization of mammalian LECT2 in vitro
The incubation experiments revealed that recombinant mam-
malian LECT2s oligomerize in vitro. Recombinant mouse LECT2
A B
DC
Fig. 1. Comparisons of electrospray ionization (ESI) mass spectra of mouse LECT2 under acidic (0.075% formic acid) and neutral (10 mM ammonium formate) conditions.
Positive ion ESI mass spectra of LECT2 under acidic (A) and neutral (B) conditions. Charge states of LECT2 protein ions are indicated. The corresponding deconvoluted spectra
of LECT2 under acidic (C) and neutral (D) conditions. The wider m/z range mass spectrum insets are shown in the upper left corner of the neutral conditions ﬁgure (B).
Calculated molecular weights are indicated.
A
B
Fig. 2. A comparison of the ﬂuorescence XAFS data at the Zn K absorption edge of
LECT2 (A) and lysostaphin (B).
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at 37 C for one day. SDS–PAGE was then performed under non-
reducing conditions, and LECT2 protein was detected by Western
blotting using an anti-mouse LECT2 polyclonal antibody. Fig. 3A
shows that the oligomerization occurred in a temperature-depen-
dent manner. As shown in Supplemental Fig. 1, the oligomerizationoccurred in a time-dependent manner. SDS–PAGE carried out un-
der reducing conditions showed a distinct pattern of oligomeriza-
tion. Strangely, ladder bands migrating at 100–250 kDa and
smear bands around the expected dimer position were detected
in reduced SDS–PAGE. As shown in Supplemental Fig. 2, DTT treat-
ment enhanced the oligomerization of LECT2 in a concentration-
dependent manner. Furthermore, the intensity of the ladder bands
migrating between 100 and 250 kDa increased over time in the
experiments carried out at the high concentration of 200 mM
DTT (Supplemental Fig. 3). Moreover, the state of the dimer in re-
duced SDS–PAGE was different from those observed in non-re-
duced SDS–PAGE. On the other hand, iodoacetate is known to be
an alkylating agent, which irreversibly reacts with cysteine to
block disulﬁde bond formation. As shown in Supplemental Fig. 4,
iodoacetate treatment inhibited higher-order oligomerization ex-
cept dimers and trimers. Strangely, the formation of lower-order
oligomers increased at 10 mM of iodoacetate. The mechanism be-
hind these oligomerization variations is not clear, but the disulﬁde
bonds among LECT2s appeared to be involved in oligomer forma-
tion. As shown in Fig. 3A, oligomers of LECT2 were not detectable
on a silver-stained gel following a 1-day incubation.
Oligomerization of recombinant human LECT2 produced by an
animal cell line has also been observed, indicating that the oligo-
merization was not unique to mouse LECT2 (Fig. 3B).
3.3. Zinc suppresses oligomerization of mammalian LECT2
As shown in Fig. 4A, treatment with EDTA as a zinc ion chelator
enhanced the oligomerization of LECT2, and Zn2+ reduced it as
compared with an untreated control (lanes 2 and 4 vs. lane 1).
EGTA treatment also enhanced the oligomerization of LECT2 to a
similar extent (lane 3). Both Ca2+ and Mg2+ ions slightly inhibited
the oligomerization (lanes 5 and 6), but that inhibition was much
lower than that seen following Zn2+ treatment. Furthermore, the
possibility that incorporation of the zinc ion was reversible in
LECT2 was explored. As shown in Fig. 4B, LECT2 was treated with
EDTA for 6 h, and then EDTA was removed by dialysis against
A B
Fig. 3. Oligomerization assay of LECT2 in vitro. (A) Reaction solutions containing recombinant mouse LECT2 were incubated for 24 h at 0 C (lanes 1 and 3) and 37 C (lanes 2
and 4). Each reaction was divided into two aliquots, and the reactions were stopped by adding SDS–PAGE sample buffer without (lanes 1 and 2) or with (lanes 3 and 4) DTT
(200 mM) and boiling (for 5 min). SDS–PAGE was then carried out on a 5–20% gradient polyacrylamide gel followed by Western blotting. A non-incubated sample was loaded
in the ﬁrst lane (C). Left image: Western blot. Right image: silver stained gel. (B) Recombinant human LECT2 was incubated for 24 h at 0 C (lane 2) and 37 C (lane 3).
A B
Fig. 4. Zinc inhibits the oligomerization of LECT2 in vitro. (A) The recombinant mouse LECT2 protein solution was incubated with chelators or divalent cations for 24 h 37 C
and then analyzed by SDS–PAGE and Western blotting. Lane: 1, control; 2, 5 mM EDTA; 3, 5 mM EGTA; 4, 5 mM ZnCl2; 5, 5 mM CaCl2; 6, 5 mM MgCl2. Left image: short
exposure of Western blot. Right image: long exposure of Western blot. (B) The effect of added zinc on EDTA-treated LECT2. Two aliquots of recombinant mouse LECT2 protein
solution were incubated with 5 mM EDTA for 6 h at 4 C and then dialyzed against buffer C (lane 2) or buffer C containing 5 mM ZnCl2 and subsequently against buffer C to
remove excess zinc ions (lane 3). In parallel, an aliquot of LECT2 solution as a control was incubated without EDTA for 6 h at 4 C and then dialyzed against buffer C (lane 1).
All dialyses were carried out at 4 C. Following the ﬁnal dialysis against fresh buffer C, all three samples were incubated for 24 h at 37 C and then analyzed by SDS–PAGE and
Western blotting.
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quently removed by dialysis against buffer C. Consequently, oligo-
merization stimulated by EDTA treatment was suppressed to
below the control level by introduction of zinc. Taken together,
these results indicated that zinc contributed to the stabilization
of the LECT2 structure and strongly suggested that incorporation
of the zinc ion in LECT2 was reversible.
4. Discussion
Zinc is known to play a structural or catalytic role in many pro-
teins [21]. The sequence homology of LECT2 with a zinc metallo-
protease family suggested that zinc might stabilize the LECT2
structure. The effect of zinc on the oligomerization state of LECT2
was therefore examined. This report presents the results ofESI-MS and XAFS analyses, which demonstrate that LECT2 contains
a non-covalently bound zinc atom. LECT2 is a member of the pep-
tidase M23 family. The structures of four proteins in this family
have been determined by X-ray crystallography (PDBj; http://
www.pdbj.org). Three additional members of the M23B subfamily
were identiﬁed by a homology search with LECT2, which contains
two conserved motifs (HxxD and HxH) that were associated with
zinc ion binding in these three proteins. Fig. 5 shows the corre-
sponding amino acid sequence alignments. Each member of this
family has one zinc ion per protein molecule. Together with ESI-
MS data presented herein, this indicates that mammalian LECT2
also binds to one zinc ion per molecule.
Our results also demonstrate that mammalian LECT2 protein
oligomerizes in vitro. Mammalian LECT2 has three disulﬁde bonds
[3]. The oligomerization was strongly affected by DTT treatment, as
Fig. 5. Alignments of the zinc binding regions of mouse LECT2 and other peptidase M23B family proteins. Q9KUL5_VIBCH; Putative uncharacterized protein VC0503 from
Vibrio cholerae, LYTM_STAA8; Glycyl-glycine endopeptidase LytM from Staphylococcus aureus strain NCTC 8325, Q9HXK8_PSEAE; Putative uncharacterized protein from
Pseudomonas aeruginosa. Putative amino acid residues that directly bind to zinc are shown in black boxes.
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the inhibition of higher-order oligomer formation by iodoacetate
treatment as shown in Supplemental Fig. 4 also reﬂects the contri-
bution of disulﬁde bonds. Dimer (occasionally trimer and tetramer)
formation was found at low temperature and in the presence of
zinc or iodoacetate. The kinetics of lower-order oligomer formation
might be faster than that of higher-order oligomer formation.
LECT2 might non-covalently form oligomers under physiological
conditions. Actually, Mim-1, which is the chicken ortholog of
LECT2, consists of two repeated units of LECT2 that associate to
form a dimer [22]. Oligomers of LECT2 were not detectable on a sil-
ver-stained gel following a 1-day incubation (Fig. 3B). A faint band
at the assumed positions for dimers was detected following a 7-
day incubation, but further oligomerization of LECT2 over that
incubation period was not observed (data not shown). Considering
the sensitivity of the silver-stain, we estimate one or less percent of
total LECT2 was involved in this reaction. The most likely explana-
tion for this low reactivity is that the most of the cysteine residues
in the recombinant LECT2 formed sulﬁde bonds. Therefore only a
small number of residual cysteine residues that did not form the
disulﬁde bonds were available to participate in this reaction. It is
known that oligomerization of a recombinant protein is occasion-
ally caused by oxidation [23,24]. On the other hand, it is possible
that another structural property of LECT2 caused the oligomeriza-
tion, as in the case of b2-microglobulin [25].
LECT2 contains a zinc atom, and zinc ions inhibited the forma-
tion of oligomers, indicating that zinc stabilizes the LECT2 struc-
ture. ESI-MS analysis has also been used to monitor protein
folding and protein complexes [26]. In comparing Fig. 1A and B,
it appears that fewer accessible protonation sites would partially
reﬂect a more compact LECT2 protein folding induced by zinc com-
plex formation. It is possible that zinc plays a crucial role in LECT2
activity as well. For example, as LECT2 is a member of the M23 pro-
tease family, we are analyzing the possibility that it is a protease.
Until now, we have not found any protease activities of LECT2 after
testing it against many possible protein substrates (serum albu-
min, carbonic anhydrase, insulin-beta chain, aprotinin and ribonu-
clease A in bovine, rabbit myosin and phosphorylase b, hen egg
ovalbumin and lysozyme, soybean trypsin inhibitor, glutathione
S-transferase of Schistosoma japonicum, maltose binding protein
and b-galactosidase of Escherichia coli; data not shown). Further-
more, we could not ﬁnd any lysostaphin-like activity of LECT2
against Staphylococcus aureus (data not shown) [27]. If LECT2 has
a protease activity, the substrate speciﬁcity might be strict. On
the other hand, LECT2 might not have a protease activity similar
to murein hydrolase activator NlpD protein, which also belongs
to the M23 protease family [28].
Recently, it has been reported that LECT2 is a novel renal amy-
loid protein [10]. Although LECT2 amyloidosis has been recognized
only recently, it does not appear to be a rare occurrence [11]. Onefeature of amyloid proteins is their beta-sheet rich structures.
Actually, some amyloid proteins, such as immunoglobulin light
chain, b2-microglobulin and lysozyme, have extensive beta-sheet
structure in their native state, and a beta-sheet may be stabilized
by protein aggregation [29]. We have already indicated that LECT2
has several beta-sheets but no alpha-helix [30]. The oligomeriza-
tion of LECT2 might offer a clue for further investigations of amy-
loid ﬁbril formation, to further clarify the mechanism of LECT2
oligomerization.
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